These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. Yang HY, Neff NH. J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170 [No Abstract] [Full Text] [Related]
24. [Activating effect of indolylhdrazides on rat brain monamine oxidase]. Safrazbekian RR, Sukasian RS, Arzanunts EM. Vopr Med Khim; 1978 Jun; 24(5):640-5. PubMed ID: 706259 [Abstract] [Full Text] [Related]
25. [Reaction of deamination of monoamines in the brain and heart of rats under the toxic action of hyperbaric oxygenation]. Gankina EM, Gol'dina OA, Shamakina IIu, Demurov EA, Koloskov IuB. Biull Eksp Biol Med; 1988 Jul; 106(7):61-4. PubMed ID: 3401582 [Abstract] [Full Text] [Related]
26. [Multiplicity of mitochondrial monoamine exidases and ways of selective blocking of the enzyme activity]. Severina IS. Biokhimiia; 1976 Jul; 41(6):955-67. PubMed ID: 829219 [Abstract] [Full Text] [Related]
27. Psychoactive drug effects and substrate-specificity in intact mitochondrial monoamine oxidase from brain [proceedings]. Gabay S, Achee FM. Psychopharmacol Bull; 1977 Jan; 13(1):45-6. PubMed ID: 13452 [No Abstract] [Full Text] [Related]
28. [Monoamine oxidation in the mitochondrial fraction of bovine kidney catalyzed by monoamine oxidase type B]. Tsukerman DB, Verevkina IV, Gorkin VZ. Vopr Med Khim; 1978 Jan; 24(4):544-8. PubMed ID: 685198 [Abstract] [Full Text] [Related]
29. Selective inhibition of the "B form" of monoamine oxidase. Magyar K, Knoll J. Pol J Pharmacol Pharm; 1977 Jan; 29(3):233-46. PubMed ID: 887501 [Abstract] [Full Text] [Related]
30. [Baygon (2-isopropoxyphenyl-N-methyl carbamate) activation of enzymatic deamination of 2-phenyl-ethylamine]. Zeĭnalov TA. Vopr Med Khim; 1985 Jan; 31(5):60-4. PubMed ID: 4090367 [Abstract] [Full Text] [Related]
31. [Mitochondrial monoamine oxidase in the brain, stomach and liver in experimental gastric ulcer and the change in their activity under the influence of quateron]. Virabian TL. Zh Eksp Klin Med; 1976 Jan; 16(5):11-9. PubMed ID: 1023702 [No Abstract] [Full Text] [Related]
35. [Monamine oxidase activity of the brain and liver mitochondria under the action of high-pressure oxygen on animals]. Bronovitskaia ZG, Goroshinskaia IA. Ukr Biokhim Zh; 1976 Jan; 48(3):295-9. PubMed ID: 960237 [Abstract] [Full Text] [Related]
37. Are there MAO inhibitors specific for dopamine metabolism? Youdim MB, Holzbauer M. Adv Biochem Psychopharmacol; 1977 Apr; 16():349-58. PubMed ID: 329649 [No Abstract] [Full Text] [Related]
38. Monoamine oxidase in health and disease. Udupa A, Srinivasan S, Udupa KN. Indian J Physiol Pharmacol; 1974 Apr; 18(2):73-85. PubMed ID: 4414711 [No Abstract] [Full Text] [Related]
39. Proceedings: Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Schurr A, Livne A. Isr J Med Sci; 1975 Nov; 11(11):1188. PubMed ID: 1205768 [No Abstract] [Full Text] [Related]
40. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria. Egashira T, Ekstedt B, Oreland L. Biochem Pharmacol; 1976 Dec 01; 25(23):2583-6. PubMed ID: 985579 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]